NCT04970290已完成不适用
Face REshaping Effect With Definisse Threads: Clinical and Instrumental Evaluation ( FREE Study)
Relife S.r.l.2 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2021年11月6日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 28
- 试验地点
- 2
- 主要终点
- Volume of midface and lower face with Definisse threads double needle and Definisse threads free floating insertion at day 30
研究概览
简要总结
The scope of this clinical trial is to evaluate and confirm thereshaping effect of the face with Definisse Threads double needle and Definisse threads free floating insertion, at day 30. 6 clinical follow up visit will be performed
详细描述
The scope of this clinical trial is to evaluate and confirm thereshaping effect of the face with Definisse Threads double needle and Definisse threads free floating insertion, at day 30. 6 clinical follow up visit will be performed to evaluate the modification of skin surface characteristics, the reshaping effect of the face, the subject's satisfaction at each visit, the presence/absence of the threads after the implantation and the global pain perception during the implant procedure..
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 30 Years 至 60 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Women, aged between 30 and 60 years (inclusive), looking for aesthetic procedures to improve the aspect of their midface and lower face.
- •Caucasian race.
- •Subjects, as per Investigator's assessment, with the degree of laxity in the middle and lower face belonging to 1-7 classes (inclusive), according to the Facial Laxity Rating Scale.
- •Subjects calm and controlled, according to the Investigator's opinion.
- •Subjects with cooperative attitude, able to comprehend the full nature and the purpose of the investigation, including possible risks, side effects and discomforts and willing to adhere to the study schedule (including attendance to the planned visits) and study prescriptions.
- •Written informed consent release prior to any study-related procedures
排除标准
- •Absolute exclusion criteria
- •Subjects presenting one or more of the following absolute exclusion criteria will not be eligible to enter the study.
- •Pregnant and breast-feeding women.
- •Subjects affected by body dysmorphic disorders.
- •Subjects with known allergy/hypersensitivity to threads components and/or lidocaine and/or clarithromycin.
- •Subjects with chronic urticaria.
- •Subjects with Quincke's edema.
- •Subjects with facial plastic surgery within previous 2 years.
- •Subjects with haemostatic or coagulation disorders (haemophilia, haemoglobin pathology, thalassemia major).
- •Subjects with active localized infection (ear, nose, or throat infections, dental abscess, periodontitis), active generalized infection (gastroenteritis, urinary bladder infection) or systemic infection (example: tuberculosis).
- •Subjects with generalized skin conditions or connective tissue disease (prominent scars, keloid, bullous diseases, cutaneous collagenosis, active psoriasis, connective tissue diseases).
- •Subjects with parotid hypertrophy.
- •Immunocompromised, oncological, diabetic subjects or with active Hashimoto's disease.
- •Subjects who underwent dental procedures within previous 2 weeks.
- •Subjects with conditions potentially causing a Koebner response.
- •Subjects with surgical medical treatments previously performed in the implant area or in the surrounding areas within previous 2 months.
- •Subjects with permanent or semi-permanent implants in the area that will be treated.
- •Subjects with active skin infection (impetigo, herpes simplex, massive demodex folliculorum, Pityrosporum, Propionibacterium acnes, viral warts).
- •Subjects who are hard smokers (more than 19 cigarettes/day).
- •Any other clinical condition that upon the judgement of the Investigator contraindicates the treatment with threads.
- •Relative exclusion criteria
- •Subjects presenting with one or more of the following relative exclusion criteria will be eligible to enter the study on the basis of the Investigator's evaluation.
- •Subjects with severe ptosis.
- •Anxious subjects.
- •Subjects with melasma and post-inflammatory hyperpigmentation.
- •Subjects with non-infectious gastrointestinal conditions like Crohn's disease or ulcerative colitis.
- •Subjects with hypertension, using anti-inflammatory and/or anticoagulant/antiaggregant medications.
- •Subjects who received filler injections or neurotoxin injection within the previous 2 months.
- •Subjects with inflammatory conditions of the skin.
- •Subjects who are mild-moderate smokers.
- •Subjects having menstruation during the day of the treatment.
结局指标
主要结局
Volume of midface and lower face with Definisse threads double needle and Definisse threads free floating insertion at day 30
时间窗: up to 30 days of treatment
The primary objective of this clinical investigation is to evaluate the reshaping effect of the face with Definisse™ thread double needle and Definisse™ thread free floating insertion, at Day 30, through 3D photos and 2D photos, through VECTRA®H2
次要结局
- reshaping effect between baseline and T15d, T4m, T8m, T12m.(up to 15 days, 4 months, 8 months and 12 monts of tratment)
- To evaluate the presence/absence of the threads after the implantation at T30d, T4m, T8m, T12m(up to 30 days, 4 months, 8 months, 12 months of treatment)
- To evaluate the global pain perception during the implant procedure at T1d and T15d.(up to 1 and 15 days of treatment)
- to evaluate the subject's satisfaction at each visit (1 day, 15 days, 30 days, 4 months, 8 months and 12 monts)(up to 1 day, 15 days, 30 days, 4 months, 8 monts and 12 months of treatment)
- To assess the clinical evaluation of reshaping effect of the total, middle and lower face comparing baseline to T15d, T30d, T4m, T8m, T12m by the non-treating investigators(up to 15 days, 30 days, 4 months,8 months, 12 months of treatment)
- To evaluate the subject's self-esteem at each visit (1 day, 15 days, 30 days, 4 months, 8 months and 12 monts) T30d, T4m, T8m, T12m).(up to 1 day, 15 ddays, 30 days, 4 months, 8 month, 12 months of treatment)
- To evaluate the modification of skin surface characteristics at 30 days, 4 months, 8 months and 12 monts from baseline(up to 30 days, 4 months, 8 months and 12 monts of tratment)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Upper Facial Remodeling With Perlane-L and DysportMild to Moderate Temporal AtrophyModerate to Severe Glabellar RhytidsModerate to Severe Periorbital RhytidsNCT01354743Beer, Kenneth R., M.D., PA20
尚未招募
不适用
Clinical Evaluation and Study of the Efficacy of a Centella Asiatica-Infused Facial Mask on Discosmetic DermatosisRosaceaCentellaMelasmaAcneNCT06763367Nanjing First Hospital, Nanjing Medical University30
已完成
2 期
Fascial Manipulation on the Treatment of Carpal Tunnel SyndromeCarpal Tunnel SyndromeNCT02495298Marta Imamura14
已完成
不适用
Safety and Efficacy of Single Therapy Versus Double and Triple Therapy of the Pellevé™ Wrinkle Treatment System for the Treatment of Moderate Facial WrinklesAppearance of Facial WrinklesNCT01299103Ellman International40
已完成
不适用
Effects of Fascia Therapy Versus Facial Manipulation on Neck PainNeck PainNCT05272111Riphah International University52